Other lipid-lowering drugs · Question 46 of 60
Which statements distinguish inclisiran from the PCSK9 antibodies?
2 answers are correct. Hard Created with AI
Show answer
Answer
- C Inclisiran blocks the production of PCSK9 in the liver cell
- D After the start phase, inclisiran is injected twice a year
Explanation
Inclisiran is a small RNA (siRNA) that suppresses the production of PCSK9 inside the liver cell. The antibodies, by contrast, capture PCSK9 that has already been released into the blood. Inclisiran is injected at the start, after three months and then every six months, the antibodies every two to four weeks.